sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Celiac Drugs Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Celiac Drugs Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Category : Pharmaceuticals and Healthcare QY Research Pages :152
Published Date : 2020-12-28

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Celiac Drugs Market with our analysts monitoring the situation across the globe.
Celiac Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Celiac Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2027. Segment by Type, the Celiac Drugs market is segmented into First Line Of Treatment Second Line Of Treatment Segment by Application, the Celiac Drugs market is segmented into Men Women Children Regional and Country-level Analysis The Celiac Drugs market is analysed and market size information is provided by regions (countries). The key regions covered in the Celiac Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2027. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2027. Competitive Landscape and Celiac Drugs Market Share Analysis Celiac Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2021. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2021. Details included are company description, major business, company total revenue and the sales, revenue generated in Celiac Drugs business, the date to enter into the Celiac Drugs market, Celiac Drugs product introduction, recent developments, etc. The major vendors covered: ADMA Biologics Amgen Anthera Pharmaceuticals Bayer Biogen BioLineRx Biotest Bristol-Myers Squibb Celgene Celimmune F Hoffmann-La Roche ImmunogenX Immunomedics ImmusanT Innovate Biopharmaceuticals Johnson & Johnson Kedrion Biopharma LFB Group Merck Novartis
1 Study Coverage 1.1 Celiac Drugs Product Introduction 1.2 Market Segments 1.3 Key Celiac Drugs Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Celiac Drugs Market Size Growth Rate by Type 1.4.2 First Line Of Treatment 1.4.3 Second Line Of Treatment 1.5 Market by Application 1.5.1 Global Celiac Drugs Market Size Growth Rate by Application 1.5.2 Men 1.5.3 Women 1.5.4 Children 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Celiac Drugs Market Size, Estimates and Forecasts 2.1.1 Global Celiac Drugs Revenue 2015-2027 2.1.2 Global Celiac Drugs Sales 2015-2027 2.2 Global Celiac Drugs, Market Size by Producing Regions: 2015 VS 2021 VS 2027 2.2.1 Global Celiac Drugs Retrospective Market Scenario in Sales by Region: 2015-2021 2.2.2 Global Celiac Drugs Retrospective Market Scenario in Revenue by Region: 2015-2021 3 Global Celiac Drugs Competitor Landscape by Players 3.1 Celiac Drugs Sales by Manufacturers 3.1.1 Celiac Drugs Sales by Manufacturers (2015-2021) 3.1.2 Celiac Drugs Sales Market Share by Manufacturers (2015-2021) 3.2 Celiac Drugs Revenue by Manufacturers 3.2.1 Celiac Drugs Revenue by Manufacturers (2015-2021) 3.2.2 Celiac Drugs Revenue Share by Manufacturers (2015-2021) 3.2.3 Global Celiac Drugs Market Concentration Ratio (CR5 and HHI) (2015-2021) 3.2.4 Global Top 10 and Top 5 Companies by Celiac Drugs Revenue in 2019 3.2.5 Global Celiac Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Celiac Drugs Price by Manufacturers 3.4 Celiac Drugs Manufacturing Base Distribution, Product Types 3.4.1 Celiac Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Celiac Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Celiac Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2027) 4.1 Global Celiac Drugs Market Size by Type (2015-2021) 4.1.1 Global Celiac Drugs Sales by Type (2015-2021) 4.1.2 Global Celiac Drugs Revenue by Type (2015-2021) 4.1.3 Celiac Drugs Average Selling Price (ASP) by Type (2015-2027) 4.2 Global Celiac Drugs Market Size Forecast by Type (2021-2027) 4.2.1 Global Celiac Drugs Sales Forecast by Type (2021-2027) 4.2.2 Global Celiac Drugs Revenue Forecast by Type (2021-2027) 4.2.3 Celiac Drugs Average Selling Price (ASP) Forecast by Type (2021-2027) 4.3 Global Celiac Drugs Market Share by Price Tier (2015-2021): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2027) 5.1 Global Celiac Drugs Market Size by Application (2015-2021) 5.1.1 Global Celiac Drugs Sales by Application (2015-2021) 5.1.2 Global Celiac Drugs Revenue by Application (2015-2021) 5.1.3 Celiac Drugs Price by Application (2015-2021) 5.2 Celiac Drugs Market Size Forecast by Application (2021-2027) 5.2.1 Global Celiac Drugs Sales Forecast by Application (2021-2027) 5.2.2 Global Celiac Drugs Revenue Forecast by Application (2021-2027) 5.2.3 Global Celiac Drugs Price Forecast by Application (2021-2027) 6 North America 6.1 North America Celiac Drugs by Country 6.1.1 North America Celiac Drugs Sales by Country 6.1.2 North America Celiac Drugs Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Celiac Drugs Market Facts & Figures by Type 6.3 North America Celiac Drugs Market Facts & Figures by Application 7 Europe 7.1 Europe Celiac Drugs by Country 7.1.1 Europe Celiac Drugs Sales by Country 7.1.2 Europe Celiac Drugs Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Celiac Drugs Market Facts & Figures by Type 7.3 Europe Celiac Drugs Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Celiac Drugs by Region 8.1.1 Asia Pacific Celiac Drugs Sales by Region 8.1.2 Asia Pacific Celiac Drugs Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Celiac Drugs Market Facts & Figures by Type 8.3 Asia Pacific Celiac Drugs Market Facts & Figures by Application 9 Latin America 9.1 Latin America Celiac Drugs by Country 9.1.1 Latin America Celiac Drugs Sales by Country 9.1.2 Latin America Celiac Drugs Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Celiac Drugs Market Facts & Figures by Type 9.3 Central & South America Celiac Drugs Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Celiac Drugs by Country 10.1.1 Middle East and Africa Celiac Drugs Sales by Country 10.1.2 Middle East and Africa Celiac Drugs Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Celiac Drugs Market Facts & Figures by Type 10.3 Middle East and Africa Celiac Drugs Market Facts & Figures by Application 11 Company Profiles 11.1 ADMA Biologics 11.1.1 ADMA Biologics Corporation Information 11.1.2 ADMA Biologics Description and Business Overview 11.1.3 ADMA Biologics Sales, Revenue and Gross Margin (2015-2021) 11.1.4 ADMA Biologics Celiac Drugs Products Offered 11.1.5 ADMA Biologics Related Developments 11.2 Amgen 11.2.1 Amgen Corporation Information 11.2.2 Amgen Description and Business Overview 11.2.3 Amgen Sales, Revenue and Gross Margin (2015-2021) 11.2.4 Amgen Celiac Drugs Products Offered 11.2.5 Amgen Related Developments 11.3 Anthera Pharmaceuticals 11.3.1 Anthera Pharmaceuticals Corporation Information 11.3.2 Anthera Pharmaceuticals Description and Business Overview 11.3.3 Anthera Pharmaceuticals Sales, Revenue and Gross Margin (2015-2021) 11.3.4 Anthera Pharmaceuticals Celiac Drugs Products Offered 11.3.5 Anthera Pharmaceuticals Related Developments 11.4 Bayer 11.4.1 Bayer Corporation Information 11.4.2 Bayer Description and Business Overview 11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2021) 11.4.4 Bayer Celiac Drugs Products Offered 11.4.5 Bayer Related Developments 11.5 Biogen 11.5.1 Biogen Corporation Information 11.5.2 Biogen Description and Business Overview 11.5.3 Biogen Sales, Revenue and Gross Margin (2015-2021) 11.5.4 Biogen Celiac Drugs Products Offered 11.5.5 Biogen Related Developments 11.6 BioLineRx 11.6.1 BioLineRx Corporation Information 11.6.2 BioLineRx Description and Business Overview 11.6.3 BioLineRx Sales, Revenue and Gross Margin (2015-2021) 11.6.4 BioLineRx Celiac Drugs Products Offered 11.6.5 BioLineRx Related Developments 11.7 Biotest 11.7.1 Biotest Corporation Information 11.7.2 Biotest Description and Business Overview 11.7.3 Biotest Sales, Revenue and Gross Margin (2015-2021) 11.7.4 Biotest Celiac Drugs Products Offered 11.7.5 Biotest Related Developments 11.8 Bristol-Myers Squibb 11.8.1 Bristol-Myers Squibb Corporation Information 11.8.2 Bristol-Myers Squibb Description and Business Overview 11.8.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2021) 11.8.4 Bristol-Myers Squibb Celiac Drugs Products Offered 11.8.5 Bristol-Myers Squibb Related Developments 11.9 Celgene 11.9.1 Celgene Corporation Information 11.9.2 Celgene Description and Business Overview 11.9.3 Celgene Sales, Revenue and Gross Margin (2015-2021) 11.9.4 Celgene Celiac Drugs Products Offered 11.9.5 Celgene Related Developments 11.10 Celimmune 11.10.1 Celimmune Corporation Information 11.10.2 Celimmune Description and Business Overview 11.10.3 Celimmune Sales, Revenue and Gross Margin (2015-2021) 11.10.4 Celimmune Celiac Drugs Products Offered 11.10.5 Celimmune Related Developments 11.1 ADMA Biologics 11.1.1 ADMA Biologics Corporation Information 11.1.2 ADMA Biologics Description and Business Overview 11.1.3 ADMA Biologics Sales, Revenue and Gross Margin (2015-2021) 11.1.4 ADMA Biologics Celiac Drugs Products Offered 11.1.5 ADMA Biologics Related Developments 11.12 ImmunogenX 11.12.1 ImmunogenX Corporation Information 11.12.2 ImmunogenX Description and Business Overview 11.12.3 ImmunogenX Sales, Revenue and Gross Margin (2015-2021) 11.12.4 ImmunogenX Products Offered 11.12.5 ImmunogenX Related Developments 11.13 Immunomedics 11.13.1 Immunomedics Corporation Information 11.13.2 Immunomedics Description and Business Overview 11.13.3 Immunomedics Sales, Revenue and Gross Margin (2015-2021) 11.13.4 Immunomedics Products Offered 11.13.5 Immunomedics Related Developments 11.14 ImmusanT 11.14.1 ImmusanT Corporation Information 11.14.2 ImmusanT Description and Business Overview 11.14.3 ImmusanT Sales, Revenue and Gross Margin (2015-2021) 11.14.4 ImmusanT Products Offered 11.14.5 ImmusanT Related Developments 11.15 Innovate Biopharmaceuticals 11.15.1 Innovate Biopharmaceuticals Corporation Information 11.15.2 Innovate Biopharmaceuticals Description and Business Overview 11.15.3 Innovate Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2021) 11.15.4 Innovate Biopharmaceuticals Products Offered 11.15.5 Innovate Biopharmaceuticals Related Developments 11.16 Johnson & Johnson 11.16.1 Johnson & Johnson Corporation Information 11.16.2 Johnson & Johnson Description and Business Overview 11.16.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2021) 11.16.4 Johnson & Johnson Products Offered 11.16.5 Johnson & Johnson Related Developments 11.17 Kedrion Biopharma 11.17.1 Kedrion Biopharma Corporation Information 11.17.2 Kedrion Biopharma Description and Business Overview 11.17.3 Kedrion Biopharma Sales, Revenue and Gross Margin (2015-2021) 11.17.4 Kedrion Biopharma Products Offered 11.17.5 Kedrion Biopharma Related Developments 11.18 LFB Group 11.18.1 LFB Group Corporation Information 11.18.2 LFB Group Description and Business Overview 11.18.3 LFB Group Sales, Revenue and Gross Margin (2015-2021) 11.18.4 LFB Group Products Offered 11.18.5 LFB Group Related Developments 11.19 Merck 11.19.1 Merck Corporation Information 11.19.2 Merck Description and Business Overview 11.19.3 Merck Sales, Revenue and Gross Margin (2015-2021) 11.19.4 Merck Products Offered 11.19.5 Merck Related Developments 11.20 Novartis 11.20.1 Novartis Corporation Information 11.20.2 Novartis Description and Business Overview 11.20.3 Novartis Sales, Revenue and Gross Margin (2015-2021) 11.20.4 Novartis Products Offered 11.20.5 Novartis Related Developments 12 Future Forecast by Regions (Countries) (2021-2027) 12.1 Celiac Drugs Market Estimates and Projections by Region 12.1.1 Global Celiac Drugs Sales Forecast by Regions 2021-2027 12.1.2 Global Celiac Drugs Revenue Forecast by Regions 2021-2027 12.2 North America Celiac Drugs Market Size Forecast (2021-2027) 12.2.1 North America: Celiac Drugs Sales Forecast (2021-2027) 12.2.2 North America: Celiac Drugs Revenue Forecast (2021-2027) 12.2.3 North America: Celiac Drugs Market Size Forecast by Country (2021-2027) 12.3 Europe Celiac Drugs Market Size Forecast (2021-2027) 12.3.1 Europe: Celiac Drugs Sales Forecast (2021-2027) 12.3.2 Europe: Celiac Drugs Revenue Forecast (2021-2027) 12.3.3 Europe: Celiac Drugs Market Size Forecast by Country (2021-2027) 12.4 Asia Pacific Celiac Drugs Market Size Forecast (2021-2027) 12.4.1 Asia Pacific: Celiac Drugs Sales Forecast (2021-2027) 12.4.2 Asia Pacific: Celiac Drugs Revenue Forecast (2021-2027) 12.4.3 Asia Pacific: Celiac Drugs Market Size Forecast by Region (2021-2027) 12.5 Latin America Celiac Drugs Market Size Forecast (2021-2027) 12.5.1 Latin America: Celiac Drugs Sales Forecast (2021-2027) 12.5.2 Latin America: Celiac Drugs Revenue Forecast (2021-2027) 12.5.3 Latin America: Celiac Drugs Market Size Forecast by Country (2021-2027) 12.6 Middle East and Africa Celiac Drugs Market Size Forecast (2021-2027) 12.6.1 Middle East and Africa: Celiac Drugs Sales Forecast (2021-2027) 12.6.2 Middle East and Africa: Celiac Drugs Revenue Forecast (2021-2027) 12.6.3 Middle East and Africa: Celiac Drugs Market Size Forecast by Country (2021-2027) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter's Five Forces Analysis 13.5 Primary Interviews with Key Celiac Drugs Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Celiac Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

Get Free Sample

List of Tables Table 1. Celiac Drugs Market Segments Table 2. Ranking of Global Top Celiac Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Celiac Drugs Market Size Growth Rate by Type 2021-2027 (K MT) & (US$ Million) Table 4. Major Manufacturers of First Line Of Treatment Table 5. Major Manufacturers of Second Line Of Treatment Table 6. Global Celiac Drugs Market Size Growth Rate by Application 2021-2027 (K MT) Table 7. Global Celiac Drugs Market Size by Region (K MT) & (US$ Million): 2021 VS 2027 Table 8. Global Celiac Drugs Sales by Regions 2015-2021 (K MT) Table 9. Global Celiac Drugs Sales Market Share by Regions (2015-2021) Table 10. Global Celiac Drugs Revenue by Regions 2015-2021 (US$ Million) Table 11. Global Celiac Drugs Sales by Manufacturers (2015-2021) (K MT) Table 12. Global Celiac Drugs Sales Share by Manufacturers (2015-2021) Table 13. Global Celiac Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2021) Table 14. Global Celiac Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Celiac Drugs as of 2019) Table 15. Celiac Drugs Revenue by Manufacturers (2015-2021) (US$ Million) Table 16. Celiac Drugs Revenue Share by Manufacturers (2015-2021) Table 17. Key Manufacturers Celiac Drugs Price (2015-2021) (USD/MT) Table 18. Celiac Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 19. Manufacturers Celiac Drugs Product Type Table 20. Date of International Manufacturers Enter into Celiac Drugs Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Global Celiac Drugs Sales by Type (2015-2021) (K MT) Table 23. Global Celiac Drugs Sales Share by Type (2015-2021) Table 24. Global Celiac Drugs Revenue by Type (2015-2021) (US$ Million) Table 25. Global Celiac Drugs Revenue Share by Type (2015-2021) Table 26. Celiac Drugs Average Selling Price (ASP) by Type 2015-2021 (USD/MT) Table 27. Global Celiac Drugs Sales by Application (2015-2021) (K MT) Table 28. Global Celiac Drugs Sales Share by Application (2015-2021) Table 29. North America Celiac Drugs Sales by Country (2015-2021) (K MT) Table 30. North America Celiac Drugs Sales Market Share by Country (2015-2021) Table 31. North America Celiac Drugs Revenue by Country (2015-2021) (US$ Million) Table 32. North America Celiac Drugs Revenue Market Share by Country (2015-2021) Table 33. North America Celiac Drugs Sales by Type (2015-2021) (K MT) Table 34. North America Celiac Drugs Sales Market Share by Type (2015-2021) Table 35. North America Celiac Drugs Sales by Application (2015-2021) (K MT) Table 36. North America Celiac Drugs Sales Market Share by Application (2015-2021) Table 37. Europe Celiac Drugs Sales by Country (2015-2021) (K MT) Table 38. Europe Celiac Drugs Sales Market Share by Country (2015-2021) Table 39. Europe Celiac Drugs Revenue by Country (2015-2021) (US$ Million) Table 40. Europe Celiac Drugs Revenue Market Share by Country (2015-2021) Table 41. Europe Celiac Drugs Sales by Type (2015-2021) (K MT) Table 42. Europe Celiac Drugs Sales Market Share by Type (2015-2021) Table 43. Europe Celiac Drugs Sales by Application (2015-2021) (K MT) Table 44. Europe Celiac Drugs Sales Market Share by Application (2015-2021) Table 45. Asia Pacific Celiac Drugs Sales by Region (2015-2021) (K MT) Table 46. Asia Pacific Celiac Drugs Sales Market Share by Region (2015-2021) Table 47. Asia Pacific Celiac Drugs Revenue by Region (2015-2021) (US$ Million) Table 48. Asia Pacific Celiac Drugs Revenue Market Share by Region (2015-2021) Table 49. Asia Pacific Celiac Drugs Sales by Type (2015-2021) (K MT) Table 50. Asia Pacific Celiac Drugs Sales Market Share by Type (2015-2021) Table 51. Asia Pacific Celiac Drugs Sales by Application (2015-2021) (K MT) Table 52. Asia Pacific Celiac Drugs Sales Market Share by Application (2015-2021) Table 53. Latin America Celiac Drugs Sales by Country (2015-2021) (K MT) Table 54. Latin America Celiac Drugs Sales Market Share by Country (2015-2021) Table 55. Latin Americaa Celiac Drugs Revenue by Country (2015-2021) (US$ Million) Table 56. Latin America Celiac Drugs Revenue Market Share by Country (2015-2021) Table 57. Latin America Celiac Drugs Sales by Type (2015-2021) (K MT) Table 58. Latin America Celiac Drugs Sales Market Share by Type (2015-2021) Table 59. Latin America Celiac Drugs Sales by Application (2015-2021) (K MT) Table 60. Latin America Celiac Drugs Sales Market Share by Application (2015-2021) Table 61. Middle East and Africa Celiac Drugs Sales by Country (2015-2021) (K MT) Table 62. Middle East and Africa Celiac Drugs Sales Market Share by Country (2015-2021) Table 63. Middle East and Africa Celiac Drugs Revenue by Country (2015-2021) (US$ Million) Table 64. Middle East and Africa Celiac Drugs Revenue Market Share by Country (2015-2021) Table 65. Middle East and Africa Celiac Drugs Sales by Type (2015-2021) (K MT) Table 66. Middle East and Africa Celiac Drugs Sales Market Share by Type (2015-2021) Table 67. Middle East and Africa Celiac Drugs Sales by Application (2015-2021) (K MT) Table 68. Middle East and Africa Celiac Drugs Sales Market Share by Application (2015-2021) Table 69. ADMA Biologics Corporation Information Table 70. ADMA Biologics Description and Major Businesses Table 71. ADMA Biologics Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 72. ADMA Biologics Product Table 73. ADMA Biologics Recent Development Table 74. Amgen Corporation Information Table 75. Amgen Description and Major Businesses Table 76. Amgen Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 77. Amgen Product Table 78. Amgen Recent Development Table 79. Anthera Pharmaceuticals Corporation Information Table 80. Anthera Pharmaceuticals Description and Major Businesses Table 81. Anthera Pharmaceuticals Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 82. Anthera Pharmaceuticals Product Table 83. Anthera Pharmaceuticals Recent Development Table 84. Bayer Corporation Information Table 85. Bayer Description and Major Businesses Table 86. Bayer Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 87. Bayer Product Table 88. Bayer Recent Development Table 89. Biogen Corporation Information Table 90. Biogen Description and Major Businesses Table 91. Biogen Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 92. Biogen Product Table 93. Biogen Recent Development Table 94. BioLineRx Corporation Information Table 95. BioLineRx Description and Major Businesses Table 96. BioLineRx Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 97. BioLineRx Product Table 98. BioLineRx Recent Development Table 99. Biotest Corporation Information Table 100. Biotest Description and Major Businesses Table 101. Biotest Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 102. Biotest Product Table 103. Biotest Recent Development Table 104. Bristol-Myers Squibb Corporation Information Table 105. Bristol-Myers Squibb Description and Major Businesses Table 106. Bristol-Myers Squibb Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 107. Bristol-Myers Squibb Product Table 108. Bristol-Myers Squibb Recent Development Table 109. Celgene Corporation Information Table 110. Celgene Description and Major Businesses Table 111. Celgene Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 112. Celgene Product Table 113. Celgene Recent Development Table 114. Celimmune Corporation Information Table 115. Celimmune Description and Major Businesses Table 116. Celimmune Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 117. Celimmune Product Table 118. Celimmune Recent Development Table 119. F Hoffmann-La Roche Corporation Information Table 120. F Hoffmann-La Roche Description and Major Businesses Table 121. F Hoffmann-La Roche Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 122. F Hoffmann-La Roche Product Table 123. F Hoffmann-La Roche Recent Development Table 124. ImmunogenX Corporation Information Table 125. ImmunogenX Description and Major Businesses Table 126. ImmunogenX Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 127. ImmunogenX Product Table 128. ImmunogenX Recent Development Table 129. Immunomedics Corporation Information Table 130. Immunomedics Description and Major Businesses Table 131. Immunomedics Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 132. Immunomedics Product Table 133. Immunomedics Recent Development Table 134. ImmusanT Corporation Information Table 135. ImmusanT Description and Major Businesses Table 136. ImmusanT Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 137. ImmusanT Product Table 138. ImmusanT Recent Development Table 139. Innovate Biopharmaceuticals Corporation Information Table 140. Innovate Biopharmaceuticals Description and Major Businesses Table 141. Innovate Biopharmaceuticals Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 142. Innovate Biopharmaceuticals Product Table 143. Innovate Biopharmaceuticals Recent Development Table 144. Johnson & Johnson Corporation Information Table 145. Johnson & Johnson Description and Major Businesses Table 146. Johnson & Johnson Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 147. Johnson & Johnson Product Table 148. Johnson & Johnson Recent Development Table 149. Kedrion Biopharma Corporation Information Table 150. Kedrion Biopharma Description and Major Businesses Table 151. Kedrion Biopharma Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 152. Kedrion Biopharma Product Table 153. Kedrion Biopharma Recent Development Table 154. LFB Group Corporation Information Table 155. LFB Group Description and Major Businesses Table 156. LFB Group Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 157. LFB Group Product Table 158. LFB Group Recent Development Table 159. Merck Corporation Information Table 160. Merck Description and Major Businesses Table 161. Merck Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 162. Merck Product Table 163. Merck Recent Development Table 164. Novartis Corporation Information Table 165. Novartis Description and Major Businesses Table 166. Novartis Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2021) Table 167. Novartis Product Table 168. Novartis Recent Development Table 169. Global Celiac Drugs Sales Forecast by Regions (2021-2027) (K MT) Table 170. Global Celiac Drugs Sales Market Share Forecast by Regions (2021-2027) Table 171. Global Celiac Drugs Revenue Forecast by Regions (2021-2027) (US$ Million) Table 172. Global Celiac Drugs Revenue Market Share Forecast by Regions (2021-2027) Table 173. North America: Celiac Drugs Sales Forecast by Country (2021-2027) (K MT) Table 174. North America: Celiac Drugs Revenue Forecast by Country (2021-2027) (US$ Million) Table 175. Europe: Celiac Drugs Sales Forecast by Country (2021-2027) (K MT) Table 176. Europe: Celiac Drugs Revenue Forecast by Country (2021-2027) (US$ Million) Table 177. Asia Pacific: Celiac Drugs Sales Forecast by Region (2021-2027) (K MT) Table 178. Asia Pacific: Celiac Drugs Revenue Forecast by Region (2021-2027) (US$ Million) Table 179. Latin America: Celiac Drugs Sales Forecast by Country (2021-2027) (K MT) Table 180. Latin America: Celiac Drugs Revenue Forecast by Country (2021-2027) (US$ Million) Table 181. Middle East and Africa: Celiac Drugs Sales Forecast by Country (2021-2027) (K MT) Table 182. Middle East and Africa: Celiac Drugs Revenue Forecast by Country (2021-2027) (US$ Million) Table 183. Key Opportunities and Drivers: Impact Analysis (2021-2027) Table 184. Key Challenges Table 185. Market Risks Table 186. Main Points Interviewed from Key Celiac Drugs Players Table 187. Celiac Drugs Customers List Table 188. Celiac Drugs Distributors List Table 189. Research Programs/Design for This Report Table 190. Key Data Information from Secondary Sources Table 191. Key Data Information from Primary Sources List of Figures Figure 1. Celiac Drugs Product Picture Figure 2. Global Celiac Drugs Sales Market Share by Type in 2021 & 2027 Figure 3. First Line Of Treatment Product Picture Figure 4. Second Line Of Treatment Product Picture Figure 5. Global Celiac Drugs Sales Market Share by Application in 2021 & 2027 Figure 6. Men Figure 7. Women Figure 8. Children Figure 9. Celiac Drugs Report Years Considered Figure 10. Global Celiac Drugs Market Size 2015-2027 (US$ Million) Figure 11. Global Celiac Drugs Sales 2015-2027 (K MT) Figure 12. Global Celiac Drugs Market Size Market Share by Region: 2021 Versus 2027 Figure 13. Global Celiac Drugs Sales Market Share by Region (2015-2021) Figure 14. Global Celiac Drugs Sales Market Share by Region in 2019 Figure 15. Global Celiac Drugs Revenue Market Share by Region (2015-2021) Figure 16. Global Celiac Drugs Revenue Market Share by Region in 2019 Figure 17. Global Celiac Drugs Sales Share by Manufacturer in 2019 Figure 18. The Top 10 and 5 Players Market Share by Celiac Drugs Revenue in 2019 Figure 19. Celiac Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 20. Global Celiac Drugs Sales Market Share by Type (2015-2021) Figure 21. Global Celiac Drugs Sales Market Share by Type in 2019 Figure 22. Global Celiac Drugs Revenue Market Share by Type (2015-2021) Figure 23. Global Celiac Drugs Revenue Market Share by Type in 2019 Figure 24. Global Celiac Drugs Market Share by Price Range (2015-2021) Figure 25. Global Celiac Drugs Sales Market Share by Application (2015-2021) Figure 26. Global Celiac Drugs Sales Market Share by Application in 2019 Figure 27. Global Celiac Drugs Revenue Market Share by Application (2015-2021) Figure 28. Global Celiac Drugs Revenue Market Share by Application in 2019 Figure 29. North America Celiac Drugs Sales Growth Rate 2015-2021 (K MT) Figure 30. North America Celiac Drugs Revenue Growth Rate 2015-2021 (US$ Million) Figure 31. North America Celiac Drugs Sales Market Share by Country in 2019 Figure 32. North America Celiac Drugs Revenue Market Share by Country in 2019 Figure 33. U.S. Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 34. U.S. Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 35. Canada Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 36. Canada Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 37. North America Celiac Drugs Market Share by Type in 2019 Figure 38. North America Celiac Drugs Market Share by Application in 2019 Figure 39. Europe Celiac Drugs Sales Growth Rate 2015-2021 (K MT) Figure 40. Europe Celiac Drugs Revenue Growth Rate 2015-2021 (US$ Million) Figure 41. Europe Celiac Drugs Sales Market Share by Country in 2019 Figure 42. Europe Celiac Drugs Revenue Market Share by Country in 2019 Figure 43. Germany Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 44. Germany Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 45. France Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 46. France Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 47. U.K. Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 48. U.K. Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 49. Italy Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 50. Italy Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 51. Russia Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 52. Russia Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 53. Europe Celiac Drugs Market Share by Type in 2019 Figure 54. Europe Celiac Drugs Market Share by Application in 2019 Figure 55. Asia Pacific Celiac Drugs Sales Growth Rate 2015-2021 (K MT) Figure 56. Asia Pacific Celiac Drugs Revenue Growth Rate 2015-2021 (US$ Million) Figure 57. Asia Pacific Celiac Drugs Sales Market Share by Region in 2019 Figure 58. Asia Pacific Celiac Drugs Revenue Market Share by Region in 2019 Figure 59. China Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 60. China Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 61. Japan Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 62. Japan Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 63. South Korea Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 64. South Korea Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 65. India Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 66. India Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 67. Australia Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 68. Australia Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 69. Taiwan Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 70. Taiwan Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 71. Indonesia Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 72. Indonesia Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 73. Thailand Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 74. Thailand Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 75. Malaysia Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 76. Malaysia Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 77. Philippines Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 78. Philippines Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 79. Vietnam Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 80. Vietnam Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 81. Asia Pacific Celiac Drugs Market Share by Type in 2019 Figure 82. Asia Pacific Celiac Drugs Market Share by Application in 2019 Figure 83. Latin America Celiac Drugs Sales Growth Rate 2015-2021 (K MT) Figure 84. Latin America Celiac Drugs Revenue Growth Rate 2015-2021 (US$ Million) Figure 85. Latin America Celiac Drugs Sales Market Share by Country in 2019 Figure 86. Latin America Celiac Drugs Revenue Market Share by Country in 2019 Figure 87. Mexico Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 88. Mexico Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 89. Brazil Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 90. Brazil Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 91. Argentina Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 92. Argentina Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 93. Latin America Celiac Drugs Market Share by Type in 2019 Figure 94. Latin America Celiac Drugs Market Share by Application in 2019 Figure 95. Middle East and Africa Celiac Drugs Sales Growth Rate 2015-2021 (K MT) Figure 96. Middle East and Africa Celiac Drugs Revenue Growth Rate 2015-2021 (US$ Million) Figure 97. Middle East and Africa Celiac Drugs Sales Market Share by Country in 2019 Figure 98. Middle East and Africa Celiac Drugs Revenue Market Share by Country in 2019 Figure 99. Turkey Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 100. Turkey Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 101. Saudi Arabia Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 102. Saudi Arabia Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 103. U.A.E Celiac Drugs Sales Growth Rate (2015-2021) (K MT) Figure 104. U.A.E Celiac Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 105. Middle East and Africa Celiac Drugs Market Share by Type in 2019 Figure 106. Middle East and Africa Celiac Drugs Market Share by Application in 2019 Figure 107. North America Celiac Drugs Sales Growth Rate Forecast (2021-2027) (K MT) Figure 108. North America Celiac Drugs Revenue Growth Rate Forecast (2021-2027) (US$ Million) Figure 109. Europe Celiac Drugs Sales Growth Rate Forecast (2021-2027) (K MT) Figure 110. Europe Celiac Drugs Revenue Growth Rate Forecast (2021-2027) (US$ Million) Figure 111. Asia Pacific Celiac Drugs Sales Growth Rate Forecast (2021-2027) (K MT) Figure 112. Asia Pacific Celiac Drugs Revenue Growth Rate Forecast (2021-2027) (US$ Million) Figure 113. Latin America Celiac Drugs Sales Growth Rate Forecast (2021-2027) (K MT) Figure 114. Latin America Celiac Drugs Revenue Growth Rate Forecast (2021-2027) (US$ Million) Figure 115. Middle East and Africa Celiac Drugs Sales Growth Rate Forecast (2021-2027) (K MT) Figure 116. Middle East and Africa Celiac Drugs Revenue Growth Rate Forecast (2021-2027) (US$ Million) Figure 117. Porter's Five Forces Analysis Figure 118. Channels of Distribution Figure 119. Distributors Profiles Figure 120. Bottom-up and Top-down Approaches for This Report Figure 121. Data Triangulation Figure 122. Key Executives Interviewed

Get Free Sample

Related Reports

Global Celiac Drugs Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Celiac Drugs Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Celiac Drugs Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Celiac Drugs Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Celiac Drugs Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)